Zydus Wellness Share Price
Sector: Food Processing
You have to be logged in to add this to Watchlist.
Login or Register
1927.95 -3.65 (-0.19%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1907.9
Today’s High
1933.75
52 Week Low
1441.75
52 Week High
2484
1916.35 -16.20 (-0.84%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1905.05
Today’s High
1938.9
52 Week Low
1440.15
52 Week High
2484
Key Metrics
- Market Cap (In Cr) 12297.23
- Beta 0.47
- Div. Yield (%) 0.26
- P/B 2.3
- TTM P/E 40.08
- Peg Ratio 1.33
- Sector P/E 22.03
- D/E 0.03
- Open Price 1929.5
- Prev Close 1931.6
Zydus Wellness Analysis
Price Analysis
-
1 Week1.89%
-
3 Months-16.44%
-
6 Month12.43%
-
YTD14.96%
-
1 Year24.41%
Risk Meter
- 33% Low risk
- 33% Moderate risk
- 33% Balanced Risk
- 33% High risk
- 33% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 2
- 1
- 0
- 0
- Buy
- 2
- 2
- 3
- 3
- Hold
- 1
- 2
- 2
- 2
- Sell
- 0
- 0
- 0
- 0
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 5
- 5
- 5
- 5
Zydus Wellness News
Complan maker plans to invest up to ₹200 crore in direct-to-consumer brands
3 min read . 02 Oct 2024Trade setup for stock market today: Five stocks to buy or sell on Monday
4 min read . 08 Jul 2024FMCG stocks: Steady monsoon, social welfare thrust likely to aid growth, says Anand Rathi
3 min read . 11 Jun 2024Zydus Wellness Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 2327.8
- Selling/ General/ Admin Expenses Total
- 492.2
- Depreciation/ Amortization
- 23.8
- Other Operating Expenses Total
- 389.1
- Total Operating Expense
- 2061.2
- Operating Income
- 266.6
- Net Income Before Taxes
- 260.1
- Net Income
- 266.9
- Diluted Normalized EPS
- 43.39
- Period
- 2024
- Total Assets
- 6148.4
- Total Liabilities
- 790.9
- Total Equity
- 5357.5
- Tangible Book Valueper Share Common Eq
- 140.99
- Period
- 2024
- Cashfrom Operating Activities
- 246.4
- Cashfrom Investing Activities
- -19.3
- Cashfrom Financing Activities
- -25.7
- Net Changein Cash
- 201.4
- Period
- 2023
- Total Revenue
- 2254.79
- Selling/ General/ Admin Expenses Total
- 695.95
- Depreciation/ Amortization
- 25.02
- Other Operating Expenses Total
- 25.09
- Total Operating Expense
- 1952.34
- Operating Income
- 302.45
- Net Income Before Taxes
- 290.86
- Net Income
- 310.37
- Diluted Normalized EPS
- 49.82
- Period
- 2023
- Total Assets
- 5833.05
- Total Liabilities
- 710.4
- Total Equity
- 5122.65
- Tangible Book Valueper Share Common Eq
- 103.82
- Period
- 2023
- Cashfrom Operating Activities
- 91.71
- Cashfrom Investing Activities
- -84.84
- Cashfrom Financing Activities
- -138.49
- Net Changein Cash
- -131.62
- Period
- 2022
- Total Revenue
- 2009.1
- Selling/ General/ Admin Expenses Total
- 627.45
- Depreciation/ Amortization
- 23.62
- Other Operating Expenses Total
- 18.08
- Total Operating Expense
- 1687.09
- Operating Income
- 322.01
- Net Income Before Taxes
- 306.02
- Net Income
- 308.87
- Diluted Normalized EPS
- 48.54
- Period
- 2022
- Total Assets
- 5692.18
- Total Liabilities
- 848.15
- Total Equity
- 4844.03
- Tangible Book Valueper Share Common Eq
- 59.49
- Period
- 2022
- Cashfrom Operating Activities
- 236.85
- Cashfrom Investing Activities
- -58.93
- Cashfrom Financing Activities
- -233.82
- Net Changein Cash
- -55.9
- Period
- 2021
- Total Revenue
- 1866.67
- Selling/ General/ Admin Expenses Total
- 624.28
- Depreciation/ Amortization
- 25.16
- Other Operating Expenses Total
- 21.84
- Total Operating Expense
- 1679.6
- Operating Income
- 187.07
- Net Income Before Taxes
- 112.21
- Net Income
- 118.73
- Diluted Normalized EPS
- 33.69
- Period
- 2021
- Total Assets
- 5666.43
- Total Liabilities
- 1098.64
- Total Equity
- 4567.79
- Tangible Book Valueper Share Common Eq
- 15.71
- Period
- 2021
- Cashfrom Operating Activities
- 286.73
- Cashfrom Investing Activities
- -10.41
- Cashfrom Financing Activities
- -216.43
- Net Changein Cash
- 59.89
- Period
- 2020
- Total Revenue
- 1766.82
- Selling/ General/ Admin Expenses Total
- 615.03
- Depreciation/ Amortization
- 26.39
- Other Operating Expenses Total
- 20.97
- Total Operating Expense
- 1516.33
- Operating Income
- 250.49
- Net Income Before Taxes
- 121.27
- Net Income
- 141.72
- Diluted Normalized EPS
- 29.56
- Period
- 2020
- Total Assets
- 5589.68
- Total Liabilities
- 2129.02
- Total Equity
- 3460.66
- Tangible Book Valueper Share Common Eq
- -174.84
- Period
- 2020
- Cashfrom Operating Activities
- 259.25
- Cashfrom Investing Activities
- -17.12
- Cashfrom Financing Activities
- -259.69
- Net Changein Cash
- -17.56
- Period
- 2019
- Total Revenue
- 842.38
- Selling/ General/ Admin Expenses Total
- 340.54
- Depreciation/ Amortization
- 12.51
- Other Operating Expenses Total
- 18.14
- Total Operating Expense
- 680.98
- Operating Income
- 161.4
- Net Income Before Taxes
- 170.63
- Net Income
- 169.14
- Diluted Normalized EPS
- 40.1
- Period
- 2019
- Total Assets
- 5458.52
- Total Liabilities
- 2072.24
- Total Equity
- 3386.28
- Tangible Book Valueper Share Common Eq
- -168.86
- Period
- 2019
- Cashfrom Operating Activities
- 218.68
- Cashfrom Investing Activities
- -4161.65
- Cashfrom Financing Activities
- 4051.53
- Net Changein Cash
- 108.56
- Period
- 2018
- Total Revenue
- 521.02
- Selling/ General/ Admin Expenses Total
- 209.62
- Depreciation/ Amortization
- 8.88
- Other Operating Expenses Total
- 9.65
- Total Operating Expense
- 404.74
- Operating Income
- 116.28
- Net Income Before Taxes
- 149.74
- Net Income
- 133.9
- Diluted Normalized EPS
- 34.27
- Period
- 2018
- Total Assets
- 828.93
- Total Liabilities
- 137.74
- Total Equity
- 691.19
- Tangible Book Valueper Share Common Eq
- 171.02
- Period
- 2018
- Cashfrom Operating Activities
- 69.06
- Cashfrom Investing Activities
- -59.12
- Cashfrom Financing Activities
- -1.82
- Net Changein Cash
- 8.12
- Period
- 2024-09-30
- Total Revenue
- 492.9
- Selling/ General/ Admin Expenses Total
- 115.6
- Depreciation/ Amortization
- 4.9
- Other Operating Expenses Total
- 100.2
- Total Operating Expense
- 478.2
- Operating Income
- 14.7
- Net Income Before Taxes
- 23.7
- Net Income
- 20.9
- Diluted Normalized EPS
- 2.46
- Period
- 2024-09-30
- Total Assets
- 6007.5
- Total Liabilities
- 513.2
- Total Equity
- 5494.3
- Tangible Book Valueper Share Common Eq
- 162.5
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 295.2
- Cashfrom Investing Activities
- -299.4
- Cashfrom Financing Activities
- -213.9
- Net Changein Cash
- -218.1
- Period
- 2024-06-30
- Total Revenue
- 841
- Selling/ General/ Admin Expenses Total
- 183.7
- Depreciation/ Amortization
- 5.1
- Other Operating Expenses Total
- 128.8
- Total Operating Expense
- 690.9
- Operating Income
- 150.1
- Net Income Before Taxes
- 151.6
- Net Income
- 147.7
- Diluted Normalized EPS
- 23.21
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 782.6
- Selling/ General/ Admin Expenses Total
- 147.9
- Depreciation/ Amortization
- 5.7
- Other Operating Expenses Total
- 117.6
- Total Operating Expense
- 626.2
- Operating Income
- 156.4
- Net Income Before Taxes
- 154.4
- Net Income
- 150.3
- Diluted Normalized EPS
- 23.62
- Period
- 2024-03-31
- Total Assets
- 6148.4
- Total Liabilities
- 790.9
- Total Equity
- 5357.5
- Tangible Book Valueper Share Common Eq
- 140.99
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 246.4
- Cashfrom Investing Activities
- -19.3
- Cashfrom Financing Activities
- -25.7
- Net Changein Cash
- 201.4
- Period
- 2023-12-31
- Total Revenue
- 403.2
- Selling/ General/ Admin Expenses Total
- 93.6
- Depreciation/ Amortization
- 6.1
- Other Operating Expenses Total
- 87.5
- Total Operating Expense
- 396.4
- Operating Income
- 6.8
- Net Income Before Taxes
- 3.7
- Net Income
- 0.3
- Diluted Normalized EPS
- 0.05
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 439.9
- Selling/ General/ Admin Expenses Total
- 99
- Depreciation/ Amortization
- 5.8
- Other Operating Expenses Total
- 83.1
- Total Operating Expense
- 429.1
- Operating Income
- 10.8
- Net Income Before Taxes
- 8.6
- Net Income
- 5.9
- Diluted Normalized EPS
- 0.93
- Period
- 2023-09-30
- Total Assets
- 5831.2
- Total Liabilities
- 624.2
- Total Equity
- 5207
- Tangible Book Valueper Share Common Eq
- 117.08
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 136.8
- Cashfrom Investing Activities
- -0.1
- Cashfrom Financing Activities
- 15.1
- Net Changein Cash
- 151.8
- Period
- 2023-06-30
- Total Revenue
- 702.1
- Selling/ General/ Admin Expenses Total
- 151.7
- Depreciation/ Amortization
- 6.2
- Other Operating Expenses Total
- 100.9
- Total Operating Expense
- 606
- Operating Income
- 96.1
- Net Income Before Taxes
- 93.4
- Net Income
- 110.4
- Diluted Normalized EPS
- 18.8
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 712.98
- Selling/ General/ Admin Expenses Total
- 110.14
- Depreciation/ Amortization
- 6.67
- Other Operating Expenses Total
- 107.62
- Total Operating Expense
- 582.21
- Operating Income
- 130.77
- Net Income Before Taxes
- 126.33
- Net Income
- 145.33
- Diluted Normalized EPS
- 23.56
- Period
- 2023-03-31
- Total Assets
- 5833.05
- Total Liabilities
- 710.4
- Total Equity
- 5122.65
- Tangible Book Valueper Share Common Eq
- 103.82
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 91.71
- Cashfrom Investing Activities
- -84.84
- Cashfrom Financing Activities
- -138.49
- Net Changein Cash
- -131.62
- Period
- 2022-12-31
- Total Revenue
- 415.58
- Selling/ General/ Admin Expenses Total
- 79.35
- Depreciation/ Amortization
- 5.88
- Other Operating Expenses Total
- 74.8
- Total Operating Expense
- 393.27
- Operating Income
- 22.31
- Net Income Before Taxes
- 19.31
- Net Income
- 19.56
- Diluted Normalized EPS
- 3.07
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Zydus Wellness Technical
Moving Average
SMA
- 5 Day1915.78
- 10 Day1935.31
- 20 Day1903.83
- 50 Day1992.01
- 100 Day2094.36
- 300 Day1872.22
Zydus Wellness Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Eid Parry India
- 830
- 5.15
- 0.62
- 879.95
- 476.3
- 14733.96
- Godrej Agrovet
- 727
- 12.45
- 1.74
- 877.85
- 475.7
- 13973.73
- Zydus Wellness
- 1927.95
- -3.65
- -0.19
- 2484
- 1441.75
- 12261.76
- LT Foods
- 348.6
- -2.85
- -0.81
- 447.95
- 160.05
- 12105.24
- Balrampur Chini Mills
- 514.9
- 6.2
- 1.22
- 692.85
- 343.45
- 10388.07
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Eid Parry India
- 17.11
- 2.07
- 14.91
- 5.58
- Godrej Agrovet
- 38.04
- 5.16
- 14.98
- 4.26
- Zydus Wellness
- 44.81
- 2.31
- 5.13
- 11.21
- LT Foods
- 19.95
- 3.51
- 16.88
- 6.26
- Balrampur Chini Mills
- 20.72
- 3.13
- 16.96
- 9.26
Zydus Wellness Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 11-Nov-24
- Quarterly Results
- 02-Aug-24
- Quarterly Results
- 14-May-24
- Audited Results & Final Dividend
- 08-Feb-24
- Quarterly Results
- 06-Nov-23
- Quarterly Results
- 03-Aug-23
- Quarterly Results
- 17-May-23
- Audited Results & Final Dividend
- 02-Feb-23
- Quarterly Results
- 10-Nov-22
- Quarterly Results
- 29-Jul-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 02-Aug-24
- 14-May-24
- AGM
- 03-Aug-23
- 17-May-23
- AGM
- 29-Jul-22
- 17-May-22
- AGM
- 30-Jul-21
- 10-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 14-May-24
- 19-Jul-24
- 19-Jul-24
- 5
- 17-May-23
- 21-Jul-23
- 21-Jul-23
- 5
- 17-May-22
- 15-Jul-22
- 14-Jul-22
- 5
- 10-May-21
- -
- 14-Jul-21
- 5